Drugs / EMLA
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT03654417 Comparator | Sep 2018 → Mar 2019 | vulvar disease | Duke University | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EMLA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03654417 ↗ |
| Route | Topical | “FDA approved for use as a topical anesthetic on the genital mucous membranes” NCT03654417 ↗ |